US Stock MarketDetailed Quotes

AURX NUO THERAPEUTICS INC

Watchlist
  • 0.530
  • 0.0000.00%
15min DelayClose Sep 24 16:00 ET
24.70MMarket Cap-7571P/E (TTM)

NUO THERAPEUTICS INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
23.70%-691.17K
29.31%-562.45K
14.53%-3.17M
18.29%-671.41K
21.18%-794.88K
20.44%-905.89K
-7.90%-795.61K
-2,989.60%-3.71M
-668.27%-821.69K
-31,864.41%-1.01M
Net income from continuing operations
38.05%-540.09K
17.17%-708.78K
0.01%-3.17M
31.93%-653.16K
13.38%-790.64K
5.65%-871.89K
-127.97%-855.76K
-3,398.11%-3.17M
-1,239.13%-959.52K
-13,420.80%-912.79K
Depreciation and amortization
-23.52%19.9K
6.48%27.52K
42.08%105.26K
12.26%27K
10.72%26.4K
24.47%26.02K
388.71%25.85K
--74.08K
--24.05K
--23.84K
Other non cash items
----
----
100.00%-1
----
----
--0
100.00%1
---146.44K
---1
--0
Change In working capital
-168.86%-174.06K
208.10%98.23K
36.45%-299.42K
-195.37%-108.33K
-30.81%-158.24K
72.63%-64.74K
114.03%31.88K
-990.16%-471.18K
330.69%113.59K
-3,463.85%-120.96K
-Change in receivables
-11.61%-75.2K
108.22%3.43K
-244.87%-318.38K
-25.68%-77.82K
-332.18%-131.38K
-205.28%-67.38K
34.70%-41.8K
---92.32K
---61.92K
---30.4K
-Change in inventory
60.77%-5.44K
-106.35%-1.78K
105.98%14.34K
-99.71%71
100.26%70
90.33%-13.87K
129.66%28.08K
---240.01K
--24.84K
---26.67K
-Change in prepaid assets
60.45%-5.99K
-95.99%756
115.11%21.91K
-56.02%3.87K
184.83%14.34K
69.71%-15.14K
121.66%18.83K
-182.44%-145.03K
117.65%8.8K
---16.91K
-Change in payables and accrued expense
-242.52%-73.06K
156.74%117.84K
-36.36%62.16K
-108.63%-13.84K
55.52%-21.16K
209.87%51.26K
45.18%45.9K
1,101.65%97.67K
26,090.03%160.28K
-1,422.78%-47.57K
-Change in other current assets
--2
--25.17K
----
----
----
--0
--0
----
----
----
-Change in other current liabilities
26.73%-14.37K
-146.68%-47.18K
13.16%-79.45K
-11.92%-20.61K
-3,560.24%-20.1K
67.54%-19.61K
-44.31%-19.13K
---91.49K
---18.42K
--581
Cash from discontinued investing activities
Operating cash flow
23.70%-691.17K
29.31%-562.45K
14.53%-3.17M
18.29%-671.41K
21.18%-794.88K
20.44%-905.89K
-7.90%-795.6K
-2,989.60%-3.71M
-668.27%-821.69K
-31,864.41%-1.01M
Investing cash flow
Cash flow from continuing investing activities
-4.1K
0
87.93%-7.24K
0
50.08%-1.9K
0
54.90%-5.34K
-59.99K
-4.65K
-3.81K
Net PPE purchase and sale
---4.1K
--0
87.93%-7.24K
--0
50.08%-1.9K
--0
54.90%-5.34K
---59.99K
---4.65K
---3.81K
Cash from discontinued investing activities
Investing cash flow
---4.1K
--0
87.93%-7.24K
--0
50.08%-1.9K
--0
54.90%-5.34K
---59.99K
---4.65K
---3.81K
Financing cash flow
Cash flow from continuing financing activities
-55.19%2M
962.5K
107.00%1.04M
224.65%4.46M
0
500K
Net common stock issuance
----
----
-55.19%2M
--962.5K
107.00%1.04M
----
----
--4.46M
--0
--500K
Cash from discontinued financing activities
Financing cash flow
--802.08K
--0
-55.19%2M
--962.5K
107.00%1.04M
--0
--0
224.65%4.46M
--0
--500K
Net cash flow
Beginning cash position
-71.94%366.23K
-55.91%928.68K
48.89%2.11M
-78.26%637.59K
-88.41%399.37K
96.16%1.31M
48.89%2.11M
776.26%1.41M
1,875.71%2.93M
2,172.54%3.44M
Current changes in cash
111.79%106.81K
29.78%-562.45K
-270.25%-1.18M
135.23%291.09K
146.50%238.22K
-132.59%-905.89K
-6.91%-800.95K
-44.81%691.64K
-165.26%-826.34K
-16,137.24%-512.29K
End cash Position
18.45%473.04K
-71.94%366.23K
-55.91%928.68K
-55.91%928.68K
-78.26%637.59K
-88.41%399.37K
96.16%1.31M
48.89%2.11M
48.89%2.11M
1,875.71%2.93M
Free cash flow
23.25%-695.27K
29.78%-562.45K
15.69%-3.18M
18.75%-671.41K
21.29%-796.78K
23.12%-905.89K
-6.91%-800.95K
-3,039.61%-3.77M
-672.62%-826.34K
-31,985.10%-1.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 23.70%-691.17K29.31%-562.45K14.53%-3.17M18.29%-671.41K21.18%-794.88K20.44%-905.89K-7.90%-795.61K-2,989.60%-3.71M-668.27%-821.69K-31,864.41%-1.01M
Net income from continuing operations 38.05%-540.09K17.17%-708.78K0.01%-3.17M31.93%-653.16K13.38%-790.64K5.65%-871.89K-127.97%-855.76K-3,398.11%-3.17M-1,239.13%-959.52K-13,420.80%-912.79K
Depreciation and amortization -23.52%19.9K6.48%27.52K42.08%105.26K12.26%27K10.72%26.4K24.47%26.02K388.71%25.85K--74.08K--24.05K--23.84K
Other non cash items --------100.00%-1----------0100.00%1---146.44K---1--0
Change In working capital -168.86%-174.06K208.10%98.23K36.45%-299.42K-195.37%-108.33K-30.81%-158.24K72.63%-64.74K114.03%31.88K-990.16%-471.18K330.69%113.59K-3,463.85%-120.96K
-Change in receivables -11.61%-75.2K108.22%3.43K-244.87%-318.38K-25.68%-77.82K-332.18%-131.38K-205.28%-67.38K34.70%-41.8K---92.32K---61.92K---30.4K
-Change in inventory 60.77%-5.44K-106.35%-1.78K105.98%14.34K-99.71%71100.26%7090.33%-13.87K129.66%28.08K---240.01K--24.84K---26.67K
-Change in prepaid assets 60.45%-5.99K-95.99%756115.11%21.91K-56.02%3.87K184.83%14.34K69.71%-15.14K121.66%18.83K-182.44%-145.03K117.65%8.8K---16.91K
-Change in payables and accrued expense -242.52%-73.06K156.74%117.84K-36.36%62.16K-108.63%-13.84K55.52%-21.16K209.87%51.26K45.18%45.9K1,101.65%97.67K26,090.03%160.28K-1,422.78%-47.57K
-Change in other current assets --2--25.17K--------------0--0------------
-Change in other current liabilities 26.73%-14.37K-146.68%-47.18K13.16%-79.45K-11.92%-20.61K-3,560.24%-20.1K67.54%-19.61K-44.31%-19.13K---91.49K---18.42K--581
Cash from discontinued investing activities
Operating cash flow 23.70%-691.17K29.31%-562.45K14.53%-3.17M18.29%-671.41K21.18%-794.88K20.44%-905.89K-7.90%-795.6K-2,989.60%-3.71M-668.27%-821.69K-31,864.41%-1.01M
Investing cash flow
Cash flow from continuing investing activities -4.1K087.93%-7.24K050.08%-1.9K054.90%-5.34K-59.99K-4.65K-3.81K
Net PPE purchase and sale ---4.1K--087.93%-7.24K--050.08%-1.9K--054.90%-5.34K---59.99K---4.65K---3.81K
Cash from discontinued investing activities
Investing cash flow ---4.1K--087.93%-7.24K--050.08%-1.9K--054.90%-5.34K---59.99K---4.65K---3.81K
Financing cash flow
Cash flow from continuing financing activities -55.19%2M962.5K107.00%1.04M224.65%4.46M0500K
Net common stock issuance ---------55.19%2M--962.5K107.00%1.04M----------4.46M--0--500K
Cash from discontinued financing activities
Financing cash flow --802.08K--0-55.19%2M--962.5K107.00%1.04M--0--0224.65%4.46M--0--500K
Net cash flow
Beginning cash position -71.94%366.23K-55.91%928.68K48.89%2.11M-78.26%637.59K-88.41%399.37K96.16%1.31M48.89%2.11M776.26%1.41M1,875.71%2.93M2,172.54%3.44M
Current changes in cash 111.79%106.81K29.78%-562.45K-270.25%-1.18M135.23%291.09K146.50%238.22K-132.59%-905.89K-6.91%-800.95K-44.81%691.64K-165.26%-826.34K-16,137.24%-512.29K
End cash Position 18.45%473.04K-71.94%366.23K-55.91%928.68K-55.91%928.68K-78.26%637.59K-88.41%399.37K96.16%1.31M48.89%2.11M48.89%2.11M1,875.71%2.93M
Free cash flow 23.25%-695.27K29.78%-562.45K15.69%-3.18M18.75%-671.41K21.29%-796.78K23.12%-905.89K-6.91%-800.95K-3,039.61%-3.77M-672.62%-826.34K-31,985.10%-1.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data